Interview with ICS-6 director Dieter Willbold on peptide therapeutics

At the 2016 TIDES Convention on Oligonucleotide and Peptide Therapeutics in Long Beach, California, ICS-6-director Prof. Dieter Willbold will deliver a talk on the "Efficiency and Oral Bioavailability of Abeta Oligomer Directed D-Enantiomeric Peptides Developed for Therapy of Alzheimer's Disease."

An Interview with Prof. Willbold can be found on the conference website: Link